ASCO Update on Bone-Modifying Drugs in Metastatic Breast Cancer - Medscape PDF Print
Medscape
In addition, the toxicity profiles are different — for example, denosumab is associated with a risk for hypocalcemia, and zoledronic acid and pamidronate are associated with a risk for renal toxicity and require renal function monitoring.

...

 
Share |
Copyright © 2025 Global Dialysis. All Rights Reserved.